SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. Hepatitis B. http://www.who.int/mediacentre/factsheets/fs204/en/ (accessed December, 18, 2012).
  • 2
    Branch of Hepatology and Infectious diseases of Chinese Medical Association. Guideline for Prevention and Treatment of Chronic Hepatitis B (2010). J Clin Hepatol. 2011, 14(2): 8189
  • 3
    Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006; 5: 14.
  • 4
    Muriel P. Role of free radicals in liver diseases. Hepatol Int. 2009; 3(4): 526536
  • 5
    Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C Lecis E Burra P Floreani A Cecchetto A Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 1995; 22(4): 449456.
  • 6
    Seronello S, Sheikh MY, Choi J. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic Biol Med. 2007; 43(6): 869882
  • 7
    Ohsawa I Ishikawa M Takahashi K Watanabe M Nishimaki K Yamagata K Katsura K Katayama Y Asoh S Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007; 13(6): 688694.
  • 8
    Cai J Kang Z Liu K Liu W Li R Zhang JH Luo X Sun X. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009; 1256: 129137.
  • 9
    Kang KM Kang YN Choi IB Gu Y Kawamura T Toyoda Y Nakao A. Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors. Med Gas Res. 2011; 1: 11.
  • 10
    Nakao A Toyoda Y Sharma P Evans M Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome: An open label pilot study. J Clin Biochem Nutr. 2010; 46(2): 140149
  • 11
    Lee WM. Cellular and humoral immunity in viral hepatitis. Am J Clin Pathol. 1976; 65(5 Suppl): 866869.
  • 12
    Yu Y Gong R Mu Y Chen Y Zhu C Sun Z Chen M Liu Y Zhu Y Wu J. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors IL-29, IL-8, and cyclooxygenase-2. J Immunol. 2011; 187(9): 48444860.
  • 13
    Swietek K, Juszczyk J. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepat. 1997; 4(2): 139141.
  • 14
    Tasdelen Fisgin N Aydin BK Sarikaya H Tanyel E Esen S Sunbul M Leblebicioglu H. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin Lab. 2012; 58(3–4): 273280.
  • 15
    Bolukbas C Bolukbas FF Horoz M Aslan M Celik H Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis. 2005; 5: 95.
  • 16
    Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs. 2005; 65(17): 24452461.
  • 17
    Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int. 2011; 31(10): 14321448.
  • 18
    Villanueva C, Kross RD. Antioxidant-induced stress. Int J Mol Sci. 2012; 13(2): 20912109.
  • 19
    Hong Y, Chen S, Zhang JM. Hydrogen as a selective antioxidant: a review of clinical and experimental studies. J Int Med Res. 2010; 38(6): 18931903.